DARATUMUMAB
daratumumab 1.8 g/15 mL injection, 15 mL vial
DARATUMUMAB (12683M)
12683M
Manner of administration:Injection
Restriction
Indication: Relapsed and/or refractory multiple myeloma
Treatment phase: Initial treatment as second-line drug therapy for weeks 1 to 9 (administered once
weekly)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 8 | DPMQ: $6,822.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Darzalex SC | |||||